Pekka Abrahamsson, PhD
Professor of Information Systems and Software Engineering, University of Jyväskylä
CEWIT2021 features a strong program of speakers who are experts in their field, and who will share their cutting-edge research and ideas with attendees. The talks will center on the five major fields which are penetrating our business and personal lives: Machine Learning, Artificial intelligence, Blockchain, Infrastructure Cybersecurity, and Computational Medicine.
Professor of Information Systems and Software Engineering,
University of Jyväskylä Global Distinguished Professor/Co-founder/ Public Diplomacy Specialist,
NYU/ Emerson Rigby Ltd./Israeli Foreign Service
Pekka Abrahamsson, PhD
Ido Aharon
CEWIT2021 will feature 4 panels: Applied AI Panel, Smart Infrastructure Panel, Drug Discovery Panel, and the Venture Capital Panel. These panels feature experts in their fields who will take part in these group discussion and take questions from their audience.
Artificial intelligence implies that a machine mimics "cognitive" functions that are normally associated with the human mind. AI is a constellation of technologies that permits machines to sense, comprehend, act and learn and is transforming the relationship between people and technology. Panelists will include distinguished speakers from Zebra Technologies, IBM Research, the University of Louisiana, and Zeblok.
Smart infrastructure technologies aim to enhance the way people live and work. This panel will explore a wide range of topics, such as cyber physical systems, IoT, robotics, cybersecurity, artificial intelligence, data visualization, blockchain, etc. Panelists will include distinguished speakers from AT&T, IBM, Twitter, the University of Massachusetts Lowell, and Stony Brook University.
The future of healing and overcoming disease rests in science and drug development. Industry-wide, more than $100 billion is spent on patients in clinical trials – accounting for 25% of budgets. In the post COVID-19 era, there is a movement to reform how drug development is conducted. The rapid development of CoVID vaccines shines a path for biopharma, regulatory agencies and health technology companies to accelerate innovation and ensure research is made accessible. These possibilities will require the consistent, widespread adoption of transformative research methods and innovative organizational approaches.
This distinguished panel is composed of lead investors from around the world. Discussion will focus on what is influencing the flow of venture capital now as to its directions and relative quantities. CEWIT Conference attendees will be invited to submit their questions during the discussion.